# Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

> **NCT02714231** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 100 (actual)

## Conditions studied

- Family Planning

## Interventions

- **DRUG:** diclofenac sodium (cataflam)
- **DRUG:** hyoscine butyl bromide (buscopan)

## Key facts

- **NCT ID:** NCT02714231
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-02
- **Final completion:** 2017-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714231, "Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02714231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*